| LINE ITEM (USD / %) | FY 2025
FILED 2026-03-28 | FY 2024
FILED 2025-03-29 | FY 2023
FILED 2024-03-30 |
|---|---|---|---|
| Revenue (Total Sales) | $2.25B | $1.91B | $1.67B |
| YoY Revenue Growth % | +17.9% | +14.6% | — |
| Gross Profit | $858.4M | $717.0M | — |
| Gross Margin % | 38.1% | 37.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $299.1M | $239.4M | $198.2M |
| Operating Margin % | 13.3% | 12.5% | 11.9% |
| Net Income (GAAP) | $225.9M | $180.9M | $147.0M |
| EBITDA (Normalized) | $442.0M | $358.0M | $258.2M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $304.9M | $147.5M | $236.1M |
| Capital Expenditures (CapEx) | $178.6M | $148.3M | $75.0M |
| Free Cash Flow (FCF) | $126.3M | -$753.0K | $161.1M |
| FCF Margin % | 5.6% | 0.0% | 9.7% |
| Return on Invested Capital (ROIC %) | 14.9% | 14.0% | 12.1% |
| Cash & Short-Term Equivalents | $200.1M | $152.9M | — |
| Total Debt (Short + Long Term) | $501.9M | $415.1M | $502.2M |
| Total Stockholders' Equity | $1.28B | $1.09B | $1.03B |